Hexavalent VaccineBefore hexavalent vaccines, infants were required to undergo a number of shots for their all-round protection against various diseases. Hexavalent vaccine combines six vaccines that act separately against tetanus, hepatitis B, pertussis, diphtheria, poliomyelitis, and haemophilus B.
The hexavalent medicine is abbreviated as DTaP-HepB-IPV-Hib or DTPa-HepB-IPV-Hib. Across the world, it is available as brands Vaxelis, Hexaxim, Hexavac, Hexyon, and more. These are sold by popular pharmaceutical companies like Panacea Biotec, EasySix, and Sanofi Pasteur.
Hexavalent Vaccine is made up of suspended diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliomyelitis (DTaP-IPV-HepB or DTPa-HBV-IPV) vaccines. These are used to reform a lyophilized Haemophilus influenzae type B (Hib) powder. GlaxoSmithKline also creates Infanrix hexa, a 3-antigen pertussis agent.
This pediatric vaccine is used in more than 90 countries, including India, Canada, Europe, Australia, and New Zealand. It is quite popular around the world due to its pain-limiting capability for little infants. However, it has not been approved by the United States of America for distribution.